SUMMARY -Th e aim of this review is to analyze current diagnostic approaches to obesity in adult men, the potential mechanisms linking obesity to infertility, and treatment options aimed at improving reproductive health. Obesity has become a worldwide epidemic with the estimated prevalence increasing from 28.8% to 36.9% between 1980 and 2013. In terms of diagnosis, numerous simple techniques have been developed including body mass index, waist to hip ratio, waist circumference, bioelectrical impedance analysis, ultrasound and skinfold measurements. Additionally, several other less available but more accurate techniques have been suggested, such as air displacement plethysmography, dual energy x-ray absorptiometry, computed tomography and magnetic resonance imaging. In addition to cardiovascular and other disorders, male obesity can negatively aff ect the male reproductive potential through abnormal reproductive hormone levels, reduced semen quality, increased release of adipose-derived hormones and adipokines, as well as thermal, genetic and sexual mechanisms. In the management of obesity related male infertility, natural weight loss is the cornerstone and regular exercise the fi rst-line treatment. Although bariatric surgery results in greater improvements in weight loss outcomes when compared to non-surgical interventions, further research is required to clarify its overall infl uence on male fertility.
Introduction
Over the past three decades, many countries in the urbanized world have witnessed a growing epidemic of overweight and obesity. Th e epidemic is largely fueled by urbanization, economic growth, industrialization, mechanized transport, and the adoption of sedentary lifestyle, coupled with the high availability of foods with high caloric content 1 . Since the 1970s, the rates of excess body weight in reproductive-age men have nearly tripled, so that in westernized countries between 65% and 70% of adult men are currently overweight or obese. Th e estimated prevalence of overweight and obesity in adults worldwide has increased between 1980 and 2013 from 28.8% to 36.9% in men and from 29.8% to 38.0% in women, reaching epidemic proportions with 2.1 billion adults aff ected 2 . Th e obesity epidemic has received considerable attention as a major global health challenge because it is associated with an increased risk of a wide array of health problems, including diabetes, heart disease, hypertension, cancers, as well as many digestive diseases, exerting a heavy toll on the economy with its massive healthcare costs 3 . Reproductive consequences of excess body weight in women have received substantial attention because obese women are more likely to experience ovulatory or menstrual disorders and delayed fertility. Th e ongoing pregnancy rate/cycle among obese women was found to be lower than in normal weight women (20.8% versus 28.3%) 4 . Moreover, obesity has been as-sociated with an increased rate of polycystic ovary syndrome, infertility and treatment failure, multiple complications of pregnancy including miscarriages, gestational diabetes, preeclampsia, fetal macrosomia and cesarean delivery with poor neonatal and maternal pregnancy outcomes 5 . Until recently, the reproductive consequences of obesity on the male reproductive potential have been studied to a lesser extent, although it has equally been linked to male infertility. Th e studies reporting correlations between obesity and fertility have generally been inconclusive because it remains unclear to what extent obesity aff ects the reproductive potential in men. In several studies, it has been suggested that overweight and obese men showed no signifi cantly increased relative risk of abnormal semen parameters [6] [7] [8] . A systematic review with meta-analysis of 31 studies on 6800 men revealed little association between increased body mass index (BMI), average sperm concentration and total sperm count. Th ere was, however, strong evidence for a negative relationship between increased BMI and the levels of testosterone, sex hormone binding globulin (SHBG) and free testosterone 6 . Th ese results support the earlier fi ndings in a study on 2139 cases where overweight and obese men had a markedly changed sex hormone profi le in serum, whereas reduction of semen quality was marginal 7 . Similarly, no signifi cant correlation was found between BMI and semen parameters measured in a recently published cross-sectional study on 511 men 8 . However, since recently, it is being increasingly documented that male excess body weight has a negative impact on semen parameters [9] [10] [11] . A recent meta-analysis including 21 studies and a sample of 13 077 men concluded that overweight and obesity were associated with an increased prevalence of azoospermia or oligozoospermia and a signifi cantly elevated risk of abnormal sperm count, when compared with normal weight subjects 9 . It seems that obesity leads to a higher risk of sperm DNA damage in infertile patients because the DNA fragmentation rate was found to be signifi cantly higher in obese, but not in overweight men 10 . When examining semen parameters, ejaculate volume, sperm concentration and total sperm count were found to show linear decline with increasing BMI and waist circumference (WC) 11 . Moreover, erectile dysfunction and low testosterone are frequently accompanied by obesity, particularly central obesity, which can also be a cause of infertility or reproductive diffi culties 12 . Furthermore, male obesity may be associated with various comorbidities, including metabolic syndrome, hypercholesterolemia, hyperleptinemia, psychological depression, sleep apnea, renal failure, type 2 diabetes mellitus and cardiovascular diseases, all of which have independently been linked to male subfertility. Th erefore, it seems that the eff ects of male obesity and comorbidities on fertility are multifactorial, infl uencing sperm parameters, pregnancy and subsequent child health. Because it is unclear to what extent obesity aff ects the reproductive potential in men, it remains to be determined whether the exact eff ects occur through its higher level per se, an associated comorbidity, or a combination of both 13 . Th e purpose of the present review is to analyze the current diagnostic methods used to defi ne obesity in adult males, the underlying mechanisms contributing to male infertility, as well as the treatment options which may lead to improvements in reproductive health.
Diagnosis of Overweight and Obesity
Currently, the terms 'overweight' and 'obesity' refer to abnormal or excessive fat accumulation that is greater than what is generally considered healthy for a given height. Th e terms also identify ranges of weight that have been shown to increase the likelihood of certain diseases, as well as other health problems 14 . Numerous simple and accessible anthropometric techniques have been developed to evaluate the body fat content such as BMI, waist to hip ratio (WHR), WC, bioelectrical impedance analysis (BIA), ultrasound and skinfold measurements [15] [16] [17] [18] [19] [20] [21] [22] [23] . Traditionally, BMI has been the most widely used method in classifying overweight and obesity in adult populations because it provides a relatively good estimate of the risks associated with developing diseases that occur more frequently in people with higher body fat content. Although BMI provides a signifi cantly better representation of the body fat content when compared to simply measuring body weight, it is only moderately correlated with the body fat mass. BMI is calculated as body weight adjusted for height (weight kg /height m 2 ) and it is the most commonly used diagnostic tool for generalized obesity. Despite its frequent use, BMI cannot be used to diff erentiate between subcutaneous and visceral fat compartments. A BMI greater than 25 kg/m is used to defi ne overweight, while a BMI over 30 kg/m 2 is characterized as obesity. Although BMI can be used in most individuals, it may overestimate adiposity in men whose higher body weight can be attributed to greater muscle and bone mass. However, BMI may also underestimate body fat in older people and others who have lost muscle mass. Th erefore, when BMI is used to indicate adiposity, gender-and age-specifi c thresholds should also be taken into account 15, 16 . In addition to BMI, alternative measurements such as WC, WHR and to a lesser extent the waist to height ratio can be used to more accurately describe the distribution of body fat. Th ese methods have been suggested as superior to BMI in predicting health problems associated with central or visceral adiposity because abdominal or white fat tissue, rather than the total amount of fat, has been linked to obesity-related disorders [17] [18] [19] . WC is usually measured at the narrowest point between the lower border of the rib cage and the iliac crest. Men and women with WC values ≤102 and ≤88 cm, respectively, are considered to have a normal WC, whereas men and women with WC values >102 and >88 cm, respectively, are considered to have a high WC 17 . WHR can also be used to predict serious health consequences as a result of increased body fat (normal WHR: males ≤0.9 and females <0.85) 18 . Although general and abdominal obesity measurements were found to be reliable predictors of obesity-related mortality, evidence from a recent meta-analysis suggests that WC or WHR provides additional information that is independent to BMI and should therefore be used in clinical practice 19 . During the last decade, the conventional BIA, a safe and cost-effi cient method, has been widely used to estimate body composition and in particular the body fat content in clinical setting. However, BIA lacks the specifi city and accuracy since it is based on measuring diff erences in resistance as the electrical current passes through fatty and lean components of the body. Th e resistance between the conductors will provide a measurement of body fat since resistance to the conduction of electricity varies between adipose, muscular and skeletal tissue. Fat-free mass (muscle) is a good conductor as it contains a large amount of water and electrolytes, while fat being anhydrous behaves as a poor conductor 20 . Recently, a newer and more accurate methodological variant, the bioelectrical impedance vector analysis (BIVA), has been used to successfully identify the relative proportion of fat mass in a large sample of adults 21 . Despite a nearly 50-year tradition of ultrasound usage to assess body fat in addition to many other body composition techniques, this method has not been adopted. Ultrasound can provide a site-specifi c evaluation of the skin, adipose tissue and muscle thicknesses, and it is being increasingly used to discriminate between visceral and subcutaneous adipose tissue. A comparison of the body fat measurements using a portable ultrasound to those measured by the calipers of the skinfold technique demonstrated no signifi cant diff erences. Moreover, the ultrasound procedure was shown to be faster and more cost eff ective than the other laboratory methods. Th e biggest limitations of using ultrasound as a body composition technique appear to be the lack of standardization in the measurement technique and the results highly dependent on the operator profi ciency. Th erefore, the availability of new, user-friendly devices with the accompanying software, designed specifi cally for body composition analysis, may be desirable in the future 22, 23 . Furthermore, several other less available techniques have also been suggested, such as air displacement plethysmography (ADP), dual energy x-ray absorptiometry (DXA), computed tomography (CT) and magnetic resonance imaging (MRI). Th ese techniques can provide the most accurate data on the fat mass and off er better quantitative assessment of visceral adiposity compared to previous general and abdominal obesity anthropometric measures. ADP and DXA can provide precise measures of fat mass but can only indirectly evaluate visceral adiposity by monitoring changes in pressure within a closed chamber or by measuring the total body and trunk fat masses 24 . For overweight and obese patients, ADP was found to be a valid measure of fat mass, fat-free mass and percent body fat when compared with values determined by the DXA criterion 25 . DXA is a simple noninvasive method with short-scanning time and virtually no radiation, which can accurately measure body composition and visceral fat with high precision and help defi ne the cardiovascular risk and the risk of diabetes 26 . Currently, x-ray, CT or MRI present valuable methods and the reference standard for studying fat deposition by providing images that generate the most accurate, very specifi c and comprehensive data, which can be used to directly assess visceral adiposity 24 . A CT scan allows separate assessment of subcutaneous and visceral fat and the visceral fat area from a single CT slice. At the L4 level, it signifi cantly correlates with the total visceral fat volume measured by the multi-slice CT scan 27 . Th e adipose tissue MRI technique provides a reliable, quantitative and noninvasive evaluation of central obesity, which is feasible in a clinical setting because it permits rapid and accurate assessment of the total and visceral adipose tissue. Th is can play a central role in the metabolic syndrome risk assessment, as well as in the visceral/total fat tissue ratio 28 .
Th e Mechanisms Linking Obesity to Male Infertility
Th e exact pathophysiology underlying the infl uence of obesity on the male reproductive potential in humans is still a matter of debate, as several possible mechanisms including hormonal, genetic or epigenetic, environmental or physical factors can play a role in addition to the negative eff ects of obesity per se 14 . Th e reproductive hormone profi les of most obese men deviate from what is considered the norm. Visceral obesity is more likely to lead to changes in hormone levels than fat stored in other parts of the body because white adipose tissue is a major endocrine organ that secretes a number of biologically active peptides and proteins including adipose-derived hormones and adipokines. Due to obesity and the increased infl ux of white adipose tissue, obese men tend to present with elevated estradiol and low testosterone levels because excess adipose tissue can possibly lead to increased aromatization of testosterone. Th e severity of obesity determines the degree to which the levels of estradiol are increased, accompanied by decreased testosterone, SHBG and inhibin B levels. It is suggested that elevated estrogen concentrations resulting from the increased conversion of androgens into estrogens may be explained by the overactivity of the aromatase cytochrome P450 enzyme, which is expressed at high levels in white adipose tissue. Th e increase in estrogen and decrease in testosterone levels, in addition to lowered levels of inhibin B, deleteriously aff ect spermatogenesis and testicular function locally. Furthermore, high estrogen levels contribute to the negative feedback eff ect in the hypothalamus leading to decreased pulses of gonadotropin-releasing hormone (GnRH) and consequently decreased release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
Th erefore, it seems that dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis as a consequence of male obesity might further explain the increased risks of sperm disorders and infertility 7, [29] [30] [31] . Another key hormone produced by white adipose tissue is leptin the production of which increases with the amount of body fat and which plays a pivotal role in regulating the energy intake and expenditure. In the hypothalamus, leptin mainly targets its receptors by counteracting the eff ects of neuropeptide Y and modulating GnRH function through glutamate signaling or through a recently identifi ed hormone called kisspeptin. Under normal conditions, leptin acts at all levels of the HPG axis increasing the production of GnRH and gonadotropins, stimulating steroidogenesis in Leydig cells, and increasing spermatogenesis by stimulating the activity of Sertoli cells. However, most of the obese individuals become insensitive to increased leptin production and develop hormonal resistance, which enables its stimulatory eff ects on the hypothalamic neurons and the resultant pituitary secretion of gonadotropins. Th erefore, hyperleptinemia in males with obesity as a consequence of GnRH/FSH/ LH disruption may contribute to aromatase overactivity in reducing testosterone levels and decreasing spermatogenesis resulting in hypogonadism and subfertility 32, 33 . Furthermore, insulin, another important mediator and modulator of the HPG axis beside leptin, has recently been reported as a contributing factor in the regulation of the male reproductive potential. As key stimulatory players, both hormones have demonstrated a direct or indirect eff ect on GnRH, LH and FSH centrally and on Leydig and Sertoli cell function locally. However, obesity is associated with increased serum and seminal insulin and leptin concentrations, which may additionally impact the male reproductive capacity leading to decreased sperm concentration and sperm vitality, and increased sperm mitochondrial membrane potential and DNA fragmentation 33, 34 . In contrast to leptin, currently available data suggest a largely inhibitory role of adiponectin on the hypothalamus, pituitary and male gonads, however, circulating levels of adiponectin are often decreased in obesity 33, 35 . Furthermore, a number of various adipokines at higher concentrations from excess white adipose tissue have been linked to male infertility. It was shown that two adipocyte-released adipokines (tumor necrosis factor-a and interleukin-6) signifi cantly reduced human sperm progressive motility in a dose-and timedependent manner, by promoting the elevation of nitric oxide production to pathological levels 36 . Moreover, increased release of adipokines results in infl ammation and can have a toxic eff ect on spermatozoa through the release of excess reactive oxygen species and reactive nitrogen species 37 . Several syndromes including Klinefelter, PraderWilli, Laurence-Moon-Bardet-Biedel, Prader-Willi and Alström due to diff erent genetic abnormalities, display to various degrees, both obesity and infertility 38 . Furthermore, aromatase polymorphism may infl uence the levels of estradiol in men by diff erentially modulating the quantitatively greater eff ects of obesity. Th is could explain why only certain obese men experience this rise in estradiol and subsequent fertility problems, whereas others experience no fertility issues 39 . Moreover, factors secreted by the adipose tissue are able to alter the epigenetic regulation of genes by which the body responds to environmental pressures critical to the reproductive function 40 . A growing number of reports suggest that chemical and physical agents in the environment, introduced and spread by human activity, may negatively aff ect male fertility. Most environmental contaminants are lipophilic and accumulate in fatty tissue around the scrotum and testes or elsewhere in the body. Epidemiological studies evaluating the impact of environmental exposures to pesticides, phthalates, polychlorinated biphenyls (PCBs), air pollution, trihalomethanes and mobile phones on semen quality suggest awareness of environmental factors which may have a detrimental eff ect on the semen quality 41 . Although PCBs were banned by most countries several decades ago, the general population continues to be exposed due to their persistence and bioaccumulation and therefore concerns regarding the altered male fertility in relation to PCBs remain present 42 . Although the results of studies analyzing the impact of pesticides on male fertility are not consistent, it seems that pesticide exposure may aff ect spermatogenesis, leading to poor semen quality and reduced reproductive potential 43 . Many obese men with increased visceral fat distribution have a higher level of scrotal fat and this can in conjunction with a more sedentary lifestyle lead to increased testicular temperature. Elevation of scrotal temperature is one of the major factors that impairs spermatogenesis and steroidogenesis in testis with varicocele and is associated with reduced sperm motility, increased sperm DNA damage and increased sperm oxidative stress. Th erefore, thermoregulatory failure leading to testicular heat stress can compromise sperm quality and increase the risk of infertility through the molecular mechanisms including apoptosis, DNA damage and autophagy 44 . On assessing the functional thermal impairment secondary to varicocele, the scrotal thermoregulatory model indicates that varicocele alters the local heat exchange processes between cutaneous layers and inner structures 45 . Although no overall association may be observed between regular physical activity and semen quality, bicycling at levels of ≥5 hours per week has been associated with a reduced sperm concentration and total sperm count 46 .
Treatment
Given the apparent correlation between obesity and male infertility, treatment approaches should primarily focus on the management of obesity and the obesity-related health issues. Th is can include lifestyle modifi cations, pharmacological interventions and surgical options. Moreover, treatments are available not only for infertility related to obesity, but also as a treatment for other comorbidities arising from obesity 14 . Lifestyle changes that lead to weight loss include diet modifi cations, as well as making conscious eff orts to exercise more in order to achieve a normal energy balance. Natural weight loss is the cornerstone and regular exercise the fi rst-line treatment of obesity-related infertility. Although reduction in body weight is mostly associated with a consistent increase in SHBG, testosterone, LH and FSH levels and a reduction in estradiol, not much is known about the impact of diet/ exercise interventions on the semen parameters in obese men 47 . In the fi rst cohort study of 44 severely obese men having participated in a 14-week weight loss program, weight loss was associated with an increase in total sperm count and semen volume in addition to improvement in testosterone, SHBG and anti-müllerian hormone levels 48 . Pharmacological methods employed in obesity-related male subfertility include the use of several drugs, such as aromatase inhibitors, estrogen receptor modulators, gonadotropins, phosphodiesterase inhibitors, and insulin-sensitizing agents 49 . Among them, aromatase inhibitors represent a highly eff ective option, which was successfully used in several case series with promising results. However, aromatase inhibitors, as well as estrogen receptor modulators, are not licensed for the treatment of male hypogonadism and/or infertility and therefore these treatments should be considered experimental until the ongoing clinical trials report their outcomes [50] [51] [52] . In conclusion, to date, there is no evidence-based treatment that increases the likelihood of pregnancy when it comes to men with obesity-induced infertility 49 . Among surgical interventions that are used in the treatment of infertility in obese men, the outcome of in vitro fertilization in mildly obese individuals was more favorable in comparison to severe or morbidly obese (BMI ≥40 kg/m 2 ) patients, as evidenced by lower pregnancy rates 53 . Th erefore, for individuals who are severely obese or who have failed to lose suffi cient weight after dietary modifi cations and pharmacological treatment, bariatric surgery is recommended as the most reliable treatment of obesity 54 . Although natural weight loss is the cornerstone in the treatment of obesity-related infertility, with promising results in restoring fertility and normal hormonal profi les, bariatric surgery results in greater improvements in terms of weight loss outcomes and weight associated comorbidities when compared with other non-surgical interventions. However, the impact of bariatric surgery on male fertility, pregnancy and miscarriage rates, as well as optimal timing of pregnancy is still unclear and therefore well structured clinical trials and further research are necessary to answer these questions 14, 55, 56 .
Conclusion
In recent years, the worldwide obesity pandemic has grown to concerning proportions. Th e negative impact of obesity on the reproductive potential of male partner has been studied to a lesser extent. Although no consensus has been reached, numerous studies clearly show that male obesity is associated with reduced fertility in men due to hormonal, genetic, physical and environmental mechanisms which ultimately lead to abnormal semen parameters. In the management of obesity-related male infertility, natural weight loss is the cornerstone and regular exercise the fi rstline treatment. Although bariatric surgery results in greater improvements in terms of weight loss outcomes in comparison to non-surgical interventions, further investigations are required to clarify its infl uence on male fertility.
